Abstract
The paper provides a brief summary of current preclinical and clinical evidences of dopaminergic system involvement in OCD pathophysiology. We also provide an overview of effectiveness and long-term safety of dopaminergic agents in the treatment of resistant OCD.
Keywords: OCD, resistant-OCD, antipsychotics augmentation, dopamine agents, ondansetron, endogenous, placebo-controlled, quetiapine, olanzapine, aripiprazole, Haloperidol, risperidone augmentation, Sydenham's chorea, amphetamine, cocaine
Current Psychopharmacology
Title: Dopamine Pharmacological Agents in Resistant-OCD
Volume: 1
Author(s): Stefano Pallanti, Giacomo Grassi and Iuliia Burian
Affiliation:
Keywords: OCD, resistant-OCD, antipsychotics augmentation, dopamine agents, ondansetron, endogenous, placebo-controlled, quetiapine, olanzapine, aripiprazole, Haloperidol, risperidone augmentation, Sydenham's chorea, amphetamine, cocaine
Abstract: The paper provides a brief summary of current preclinical and clinical evidences of dopaminergic system involvement in OCD pathophysiology. We also provide an overview of effectiveness and long-term safety of dopaminergic agents in the treatment of resistant OCD.
Export Options
About this article
Cite this article as:
Pallanti Stefano, Grassi Giacomo and Burian Iuliia, Dopamine Pharmacological Agents in Resistant-OCD, Current Psychopharmacology 2012; 1 (1) . https://dx.doi.org/10.2174/2211556011201010044
DOI https://dx.doi.org/10.2174/2211556011201010044 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Can We Select Patients for Colorectal Cancer Prevention with Aspirin?
Current Pharmaceutical Design Isoform Selective Phosphoinositide 3-Kinase γ and δ Inhibitors and Their Therapeutic Potential
Recent Patents on Inflammation & Allergy Drug Discovery Patent Review on Laser Interference Lithography Technique for Producing Periodic Nanostructure
Recent Patents on Nanotechnology Evaluating the Susceptibility of Mitochondrial DNA Germline Mutations in Chinese Cancer Patients
Current Molecular Medicine Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
Current Pharmaceutical Design Expanding Spectrum of Sodium Potassium Chloride Co-transporters in the Pathophysiology of Diseases
Current Neuropharmacology Quinoline: An Attractive Scaffold in Drug Design
Mini-Reviews in Medicinal Chemistry A Preliminary X-Ray Study of a Refolded PTS EIIBfruc Protein from Escherichia coli
Protein & Peptide Letters Phytochemicals as Adjunctive with Conventional Anticancer Therapies
Current Pharmaceutical Design Hypothalamic and Neuroendocrine Changes in Huntingtons Disease
Current Drug Targets Analytical Strategies to Disclose Repeated Consumption of New Psychoactive Substances by Hair Analysis
Current Pharmaceutical Biotechnology Neural Basis of Anhedonia and Amotivation in Patients with Schizophrenia: The Role of Reward System
Current Neuropharmacology Myocardial Infarction. Pathological Relevance and Relationship with Coronary Risk Factors
Current Pharmaceutical Design Sphingolipids in Inflammation: Roles and Implications
Current Molecular Medicine Inflammatory Cytokines in Acute Ischemic Stroke
Current Pharmaceutical Design The Problem of False-Positive Human Papillomavirus DNA Tests in Cervical Screening
Current Pharmaceutical Design Metabolism of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol, A Review, with Emphasis on the Pharmacology of Fatty Acid Amide Hydrolase, A Possible Target for the Treatment of Neurodegenerative Diseases and Pain
Current Medicinal Chemistry - Central Nervous System Agents Promises of Nanotechnology for Drug Delivery to Brain in Neurodegenerative Diseases
Current Nanoscience Pd-In and Pd-Fe as New Types of Ni-Free Top Coatings for Decorative Applications
Innovations in Corrosion and Materials Science (Discontinued) Analgesia Induced by Morphine Microinjected into the Nucleus Raphe Magnus: Effects on Tonic Pain
Current Drug Delivery